Actavis Gets Go-Ahead to Expand Generic Painkiller Portfolio
Actavis gets go-ahead to expand generic painkiller portfolio
The FDA approved Actavis' application to manufacture 5mg, 10mg, 20mg, 30mg and 40mg doses of the oxymorphone hydrochloride extended-release tablets on Friday. Actavis already had the agency's OK to make 7.5mg … Schedule II drugs include agents like … Read more on Medical Marketing and Media